Page last updated: 2024-12-07

benzyloxyresorufin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Benzyloxyresorufin (BRF) is a fluorescent substrate used in various assays to measure the activity of cytochrome P450 enzymes. Its synthesis involves the reaction of resorufin with benzyl bromide. BRF is a non-fluorescent compound that is converted to the highly fluorescent resorufin upon enzymatic cleavage by P450 enzymes. This property makes it a sensitive and specific probe for measuring P450 activity in various biological samples, including cell lysates, tissues, and in vivo models. The importance of BRF lies in its ability to provide valuable information about P450 enzyme activity, which is crucial for drug metabolism, detoxification, and hormone synthesis. Researchers study BRF to understand the mechanisms of drug metabolism, identify potential drug interactions, and develop new drug candidates with improved pharmacokinetic profiles. BRF is also used to evaluate the effects of environmental toxins on P450 enzymes and to assess the efficacy of drug therapies targeting these enzymes.'

Cross-References

ID SourceID
PubMed CID114982
SCHEMBL ID563335
MeSH IDM0161466

Synonyms (21)

Synonym
7-(phenylmethoxy)-3h-phenoxazin-3-one
AKOS005429005
benzyloxyresorufin
87687-02-3
7-benzoxyresorufin
STK299141
7-(benzyloxy)-3h-phenoxazin-3-one
resorufin benzyl ether, cyp450 substrate
7-phenylmethoxyphenoxazin-3-one
resorufin benzyl ether
3h-phenoxazin-3-one, 7-(phenylmethoxy)-
7-benzyloxyresorufin
FT-0642066
7-benzyloxy-3h-phenoxazin-3-one
SCHEMBL563335
J-100240
DTXSID90236553
E79435
bzres [resorufin benzyl ether]
CS-0010055
HY-D0146

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" Verify its use for studying drug-drug interactions."( An in silico transwell device for the study of drug transport and drug-drug interactions.
Garmire, DG; Garmire, LX; Hunt, CA, 2007
)
0.34
" Those components were used to exemplify drug-drug interaction studies."( An in silico transwell device for the study of drug transport and drug-drug interactions.
Garmire, DG; Garmire, LX; Hunt, CA, 2007
)
0.34
"The ISTD is an example of a new class of simulation models capable of realistically representing complex drug transport and drug-drug interaction phenomena."( An in silico transwell device for the study of drug transport and drug-drug interactions.
Garmire, DG; Garmire, LX; Hunt, CA, 2007
)
0.34

Dosage Studied

ExcerptRelevanceReference
"The O-dealkylation of pentoxyresorufin, a substrate for P450 2B1, was decreased in lung microsomes from rats dosed with O,O,S-trimethylphosphorodithioate, O,O,O-trimethylphosphorothioate, bromophos, fenitrothion, p-xylene and 2,4-dichloro-(6-phenylphonoxy)ethylamine."( Inhibition and induction of cytochrome P450 isoenzymes in rat lung.
Dinsdale, D; Verschoyle, RD; Wolf, CR, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.00)18.7374
1990's11 (55.00)18.2507
2000's5 (25.00)29.6817
2010's3 (15.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.54 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index5.40 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]